大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/09/17 | 8,415 | 8,415 | 8,137 | 8,137 | -338 | -4% | 1,116,000 |
2025/09/16 | 8,471 | 8,551 | 8,418 | 8,475 | -31 | -0.4% | 1,060,300 |
2025/09/12 | 8,553 | 8,559 | 8,387 | 8,506 | +103 | +1.2% | 1,323,800 |
2025/09/11 | 8,320 | 8,445 | 8,316 | 8,403 | +87 | +1% | 742,500 |
2025/09/10 | 8,495 | 8,513 | 8,316 | 8,316 | -196 | -2.3% | 1,155,100 |
2025/09/09 | 8,517 | 8,614 | 8,500 | 8,512 | +35 | +0.4% | 1,274,000 |
2025/09/08 | 8,551 | 8,599 | 8,396 | 8,477 | +226 | +2.7% | 977,700 |
2025/09/05 | 8,136 | 8,251 | 8,115 | 8,251 | +83 | +1% | 882,300 |
2025/09/04 | 8,107 | 8,180 | 8,057 | 8,168 | +152 | +1.9% | 845,100 |
2025/09/03 | 8,051 | 8,139 | 7,964 | 8,016 | -26 | -0.3% | 933,100 |
2025/09/02 | 7,912 | 8,066 | 7,912 | 8,042 | +108 | +1.4% | 779,700 |
2025/09/01 | 7,868 | 8,037 | 7,852 | 7,934 | +168 | +2.2% | 938,800 |
2025/08/29 | 7,764 | 7,828 | 7,742 | 7,766 | -72 | -0.9% | 830,200 |
2025/08/28 | 7,876 | 7,930 | 7,836 | 7,838 | +2 | ±0% | 723,300 |
2025/08/27 | 7,804 | 7,902 | 7,764 | 7,836 | -57 | -0.7% | 858,600 |
2025/08/26 | 8,019 | 8,036 | 7,790 | 7,893 | -127 | -1.6% | 2,371,900 |
2025/08/25 | 7,985 | 8,058 | 7,964 | 8,020 | -46 | -0.6% | 717,400 |
2025/08/22 | 8,030 | 8,105 | 8,014 | 8,066 | +62 | +0.8% | 819,200 |
2025/08/21 | 8,130 | 8,159 | 7,978 | 8,004 | -69 | -0.9% | 1,301,100 |
2025/08/20 | 8,153 | 8,245 | 8,048 | 8,073 | -80 | -1% | 1,222,700 |
2025/08/19 | 7,940 | 8,157 | 7,924 | 8,153 | +229 | +2.9% | 1,142,300 |
2025/08/18 | 7,890 | 8,011 | 7,856 | 7,924 | +34 | +0.4% | 642,300 |
2025/08/15 | 7,964 | 7,998 | 7,786 | 7,890 | +37 | +0.5% | 1,065,900 |
2025/08/14 | 8,001 | 8,046 | 7,793 | 7,853 | -148 | -1.8% | 1,250,300 |
2025/08/13 | 7,950 | 8,029 | 7,892 | 8,001 | +130 | +1.7% | 1,465,200 |
2025/08/12 | 7,849 | 7,981 | 7,802 | 7,871 | +60 | +0.8% | 1,307,000 |
2025/08/08 | 7,615 | 7,840 | 7,586 | 7,811 | +172 | +2.3% | 1,476,200 |
2025/08/07 | 7,479 | 7,677 | 7,445 | 7,639 | +71 | +0.9% | 1,010,300 |
2025/08/06 | 7,415 | 7,588 | 7,388 | 7,568 | +151 | +2% | 1,141,400 |
2025/08/05 | 7,365 | 7,423 | 7,223 | 7,417 | +53 | +0.7% | 1,463,600 |
2025/08/04 | 7,418 | 7,431 | 7,288 | 7,364 | -94 | -1.3% | 1,207,200 |
2025/08/01 | 7,416 | 7,619 | 7,372 | 7,458 | +155 | +2.1% | 1,553,900 |
2025/07/31 | 7,170 | 7,428 | 7,040 | 7,303 | +67 | +0.9% | 3,075,500 |
2025/07/30 | 7,190 | 7,255 | 7,104 | 7,236 | +13 | +0.2% | 5,242,400 |
2025/07/29 | 7,116 | 7,262 | 7,083 | 7,223 | +213 | +3% | 2,077,300 |
2025/07/28 | 7,012 | 7,107 | 7,000 | 7,010 | -51 | -0.7% | 1,003,200 |
2025/07/25 | 6,995 | 7,149 | 6,950 | 7,061 | +134 | +1.9% | 2,012,600 |
2025/07/24 | 6,859 | 6,999 | 6,805 | 6,927 | +81 | +1.2% | 1,710,000 |
2025/07/23 | 6,709 | 6,905 | 6,662 | 6,846 | +315 | +4.8% | 2,170,500 |
2025/07/22 | 6,512 | 6,781 | 6,511 | 6,531 | -50 | -0.8% | 1,870,100 |
2025/07/18 | 6,717 | 6,720 | 6,581 | 6,581 | -80 | -1.2% | 1,054,900 |
2025/07/17 | 6,580 | 6,661 | 6,571 | 6,661 | +74 | +1.1% | 967,500 |
2025/07/16 | 6,599 | 6,616 | 6,540 | 6,587 | ±0 | ±0% | 909,900 |
2025/07/15 | 6,664 | 6,671 | 6,565 | 6,587 | -33 | -0.5% | 834,700 |
2025/07/14 | 6,634 | 6,695 | 6,591 | 6,620 | -70 | -1% | 859,900 |
2025/07/11 | 6,675 | 6,763 | 6,620 | 6,690 | +90 | +1.4% | 1,365,200 |
2025/07/10 | 6,651 | 6,668 | 6,572 | 6,600 | -86 | -1.3% | 1,540,900 |
2025/07/09 | 6,694 | 6,700 | 6,620 | 6,686 | +64 | +1% | 1,356,600 |
2025/07/08 | 6,670 | 6,679 | 6,583 | 6,622 | -109 | -1.6% | 1,601,400 |
2025/07/07 | 6,750 | 6,785 | 6,703 | 6,731 | -41 | -0.6% | 739,700 |
1~
50
件表示中 / 3611件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 813,700円 | +2.2% | +28.0% | 1.72% | 13.02倍 | 1.58倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
武 田 | 443,000円 | -1.1% | +75.3% | 4.51% | 30.69倍 | 1.01倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 353,000円 | +6.0% | +4.0% | 2.21% | 21.78倍 | 4.02倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
アステラス薬 | 165,500円 | +0.9% | +380.2% | 4.71% | 22.80倍 | 1.96倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 261,300円 | +20.9% | +10.6% | 2.53% | 12.36倍 | 1.63倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム